The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Pfizer has reached agreements with Dexcel Pharma, Hikma Pharmaceuticals and Cipla, regarding lawsuits filed in the U.S. District Court for the District of Delaware. Vyndamax remains the market leader ...

Pfizer's third-quarter performance bested Wall Street estimates thanks to an Eliquis beat and 37% growth from acquired products.

By Mariam Sunny and Christy Santhosh Nov 3 (Reuters) - Pfizer raised its full-year profit and revenue forecasts on Tuesday as ...

Pfizer (PFE) is reiterated as a Buy, supported by the world's largest drug pipeline and trading below intrinsic value, despite near-term headwinds. PFE maintains strong free cash flow and improved ...

TORONTO/NEW YORK (Reuters) - Apotex Inc said on Wednesday it would immediately launch in Canada a copycat form of Pfizer Inc's blockbuster Lipitor cholesterol fighter, and Pfizer vowed to fight back ...

(Reuters) - U.S. regulators granted Pfizer Inc a reissued patent on its multibillion-dollar Celebrex pain drug that extends its marketing exclusivity until early December 2015, the company said on ...